Management Team
Richard J. MacKay
Chairman
With over 50 years of experience in the pharmaceutical industry, Richard J. MacKay is now recognized as an icon within the field of dermatology. In 1976,he fathered the Canadian division of Stiefel Labratories Inc. and is directly responsible for establishing the level of success it boasts today.
Dick joins Valeo Pharma as Chairman with a wealth of knowledge and an unparalleled level of expertise in pharmaceutical sales and marketing.
Steve Saviuk
President and CEO
Steve has an extensive background in finance and venture capital investing including a number of successful health science companies. He co-founded Valeo Pharma in 2003 and has served as its President and CEO since its inception and has overseen its transformation from its early years as an in-licensor of established brands to a fast growing full service Canadian pharmaceutical company.
Marc Leger
Executive VP Sales
Marc has over 25 years of experience in the Pharmaceutical industry in both Canada and the U.S. Included in this background is General Manager experience, as well as several senior VP positions in Sales and Marketing, in both the prescription and OTC businesses. Leger has built a reputation for success in Business Management through strong leadership and a solid track record for launching #1 in class brands. Leger joins Valeo with an extensive background in Dermatology from Schering-Plough.
Kristof Biniecki, Ph.D. in Pharmacy
Vice President Scientific Affairs
With over 25 years of experience with a multinational in the areas of Quality Assurance, Quality Control and Regulatory Affairs, he successfully launched several Rx and OTC products. These functions also entailed global custom manufacturing involving international audits and on site project development. As a result, his expertise in product development from the early stages of drug submission preparation up to its commercialization is extremely beneficial to the Valeo Pharma team.
John Di Genova
Vice President Business Development
Over 25 years of industry experience in production, marketing, sales and new product development in the generic and innovative pharmaceutical industry. Licensed pharmacist with experience with CIVA and injectable compounding.
Helen Saviuk, C.A.
Chief Financial Officer
Helen has held various positions in financial accounting throughout her extensive career. She has been active in Valeo since its inception in 2003 and was involved in setting the base structure for various departments of the company, specifically concentrating on inventory planning and finance.